INSIGHTS ON DRUG DEVELOPMENT
-
From 51% Yield To 87% With Targeted Impurity Removal
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging
High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.
-
Data-Driven Strategies To De-Risk OSD Development
Watch as Quentin Horgan, Director of Drugs Intelligence at GlobalData discusses how early-stage insights can improve development outcomes and reduce downstream risk.
-
Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody
Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.
-
Bioanalytical Quantification Of A Biotherapeutic Peptide7/17/2025
Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.
-
Together, Let's Sail Toward Success7/23/2025
Explore the promise and complexity of gene therapy and see how Cytiva empowers scientists to overcome challenges and accelerate life-changing treatments from lab to patient.
-
Overcoming Challenges In Ophthalmic Formulations8/27/2025
Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
Extraction And Chemical Characterization Pitfalls In Complex Medical Devices8/20/2026
Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.
-
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success2/26/2025
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
DRUG DEVELOPMENT SOLUTIONS
-
The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.
-
High-intensity sweeteners can improve palatability across oral dosage forms. Learn more about taste-masking performance, sweetness potency, and solubility to make a more informed excipient selection.
-
Gain insight into how a connected approach to experimental design and data management helps reduce errors, accelerate iteration cycles, and unlock deeper insights.
-
Understand and predict human response earlier in the drug development process, and harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.
-
Leica M60 Routine Stereo Microscopes
Easily inspect, screen, observe or document. Handle your daily inspection or documentation, work confidently, and stay flexible in times of change. The modular stereo microscopes of the M series from Leica are the right choice for an abundant variety of tasks in life sciences and industrial applications.
The M50, M60, and M80 allow operators to see a large sample overview, work comfortably under the microscope, and capture images of important details easily.